Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2010. Start Trial.
Date Value
October 23, 2026 8.671
October 22, 2026 8.702
October 21, 2026 8.997
October 20, 2026 9.145
October 19, 2026 8.745
October 16, 2026 8.382
October 15, 2026 9.059
October 14, 2026 8.745
October 13, 2026 8.924
October 12, 2026 8.960
October 09, 2026 8.997
October 08, 2026 8.191
October 07, 2026 7.948
October 06, 2026 7.976
October 05, 2026 8.708
October 02, 2026 8.748
October 01, 2026 8.757
September 30, 2026 9.120
September 29, 2026 8.893
September 28, 2026 6.763
September 25, 2026 6.770
September 24, 2026 6.646
September 23, 2026 6.271
September 22, 2026 6.548
September 21, 2026 6.271
Date Value
September 18, 2026 6.308
September 17, 2026 6.166
September 16, 2026 6.074
September 15, 2026 5.760
September 14, 2026 5.699
September 11, 2026 5.293
September 10, 2026 5.010
September 09, 2026 5.188
September 08, 2026 5.354
September 04, 2026 5.410
September 03, 2026 5.354
September 02, 2026 5.305
September 01, 2026 5.096
August 31, 2026 5.028
August 28, 2026 4.930
August 27, 2026 5.083
August 26, 2026 4.973
August 25, 2026 5.194
August 24, 2026 4.960
August 21, 2026 5.102
August 20, 2026 5.533
August 19, 2026 4.917
August 18, 2026 4.326
August 17, 2026 4.369
August 14, 2026 4.296

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
AVITA Medical, Inc. --
Halozyme Therapeutics, Inc. 99.81
CareDx, Inc. 8.372
Amgen, Inc. 20.32
Xencor, Inc. 3.719

Price to Book Value Related Metrics

PS Ratio 17.78
Price 14.09
Earnings Yield -5.12%
Market Cap 6.382B